New CDER Impact Story on Recurrent Neural Networks for Modeling Drug Exposure and Drug Response – Drug Information Update

If your email program has trouble displaying this email, view it as a web page.   A New Approach to Pharmacometrics: Recurrent Neural Networks for Modeling Drug Exposure and Drug Response CDER has successfully used its machine learning model to predict the pharmacodynamic responses of individuals encountering dosing regimens differing from input data from which the model was constructed. This finding is significant, because changes in dosing regimens must often be considered over the course of a drug development process. Read More This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO- FDA (1-888-463-6332) or 301-796-3400 from 8:00 am - 4:30 pm ET Monday - Friday. You can also email us at: druginfo@fda.hhs.gov. Stay Connected with U.S. Food and Drug Administration:         SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA